previous
show
infect
rat
oligodendrocyt
ultraviolet
lightinactiv
mous
hepat
viru
mhv
result
apoptosi
suggest
apoptosi
trigger
cell
entri
character
earliest
apoptot
signal
event
treat
cell
antibodi
specif
mhv
receptor
prior
viru
infect
antibodi
specif
mhv
spike
protein
follow
viru
bind
treatment
block
viru
infect
apoptosi
indic
virusreceptor
bind
necessari
suffici
apoptosi
induct
furthermor
viru
infect
significantli
increas
format
deathreceptor
complex
consist
fa
fasassoci
death
domain
induc
complex
involv
tumor
necrosi
factor
receptor
associ
death
domain
demonstr
specif
activ
fa
signal
pathway
moreov
viru
infect
alter
abund
individu
protein
complex
suggest
activ
fa
signal
pathway
posttransl
level
treatment
fasfc
chimera
block
fasfa
ligandmedi
apoptosi
inhibit
format
complex
block
activ
apoptosi
mhvinfect
cell
also
inhibit
releas
cytochrom
c
mitochondria
activ
result
demonstr
oligodendrocyt
apoptosi
trigger
mhv
infect
cell
entri
activ
fa
signal
pathway
apoptosi
import
biolog
process
regul
homeostasi
tissu
develop
immun
system
nijhawan
et
al
roulston
et
al
wylli
initi
apoptosi
usual
follow
cascad
signal
event
apoptot
pathway
upon
receipt
varieti
apoptot
signal
common
apoptot
pathway
death
receptormedi
signal
pathway
involv
interact
apoptot
factor
cell
surfac
molecul
fa
fasligand
susin
et
al
tumor
necrosi
factor
receptor
tnfr
tnf
activ
fa
tnfr
signal
pathway
facilit
recruit
adaptor
protein
fasassoci
death
domain
fadd
tnfrassoci
death
domain
tradd
protein
turn
recruit
initi
caspas
form
deathreceptor
complex
preapoptosom
hsu
et
al
procaspas
preapoptosom
undergo
cleavag
form
activ
caspas
activ
initi
caspas
activ
effector
caspas
ie
ultim
lead
apoptosi
cohen
hsu
et
al
nijhawan
et
al
strasser
et
al
anoth
wellcharacter
apoptot
pathway
mitochondriamedi
pathway
activ
either
extracellular
intracellular
death
signal
strasser
et
al
vaux
et
al
activ
mitochondri
pathway
trigger
cytochrom
c
releas
interact
cytochrom
complex
turn
activ
initi
subsequ
effector
lead
apoptosi
cohen
apoptosi
trigger
divers
intrins
extrins
signal
includ
viru
infect
mani
virus
abil
induc
apoptosi
host
cell
one
cytolyt
properti
viral
infect
murin
coronaviru
mous
hepat
viru
mhv
envelop
rna
viru
infect
rodent
caus
enter
hepat
central
nervou
system
cn
diseas
depend
genet
background
viru
strain
host
cn
diseas
caus
mhv
infect
vari
significantli
rang
acut
fatal
enceph
persist
infect
without
chronic
demyelin
stohlman
et
al
precis
mechan
cn
demyelin
caus
mhv
infect
known
although
experiment
evid
strongli
suggest
immun
compon
play
import
role
initi
progress
robust
cn
demyelin
diseas
follow
mhv
infect
dandekar
perlman
fleme
et
al
houtman
fleme
wang
et
al
wu
et
al
wu
perlman
addit
apoptot
oligodendrocyt
detect
vicin
demyelin
lesion
mhvinfect
mice
rat
baraclata
et
al
schwartz
et
al
wu
perlman
previous
observ
cultur
rat
oligodendrocyt
suscept
mhv
infect
mhv
replic
sever
restrict
liu
et
al
moreov
infect
oligodendrocyt
mhv
result
apoptot
cell
death
apoptosi
caspas
depend
liu
et
al
subsequ
found
mitochondri
signal
pathway
also
activ
mhv
infect
liu
et
al
howev
upstream
signal
trigger
activ
apoptosi
determin
current
studi
character
upstream
apoptot
signal
pathway
activ
differenti
cell
line
rat
oligodendrocyt
mhv
infect
result
indic
virusreceptor
bind
necessari
suffici
apoptosi
induct
fusion
viru
envelop
cell
membran
mediat
viral
spike
protein
cell
entri
like
trigger
apoptosi
furthermor
found
mhv
infect
induc
format
preapoptosom
consist
fa
fadd
inhibit
fa
signal
pathway
solubl
receptor
block
preapoptosom
format
activ
apoptosi
thu
result
demonstr
mhvinduc
oligodendrocyt
apoptosi
mediat
via
activ
fa
signal
pathway
previous
show
uvinactiv
mhv
could
still
induc
oligodendrocyt
apoptosi
indic
apoptosi
like
induc
cell
entri
liu
et
al
find
also
suggest
activ
apoptot
pathway
either
trigger
direct
interact
virion
surfac
protein
viral
receptor
attach
andor
fusion
viral
envelop
cell
membran
test
possibl
treat
cell
monoclon
antibodi
term
specif
mhv
receptor
dveksler
et
al
infect
determin
effect
apoptosi
induct
first
determin
viru
titer
follow
treatment
cell
antibodi
result
confirm
effect
antibodi
treatment
block
viru
infect
evidenc
decreas
approxim
log
viru
titer
fig
parallel
experi
apoptosi
measur
propidium
iodid
pi
stain
cell
liveand
uvinactiv
virus
respect
antibodytr
sampl
result
similar
mockinfect
cell
howev
mocktreat
virusinfect
sampl
cell
apoptosisposit
fig
similar
result
obtain
annexin
v
stain
fig
result
indic
virusreceptor
interact
requir
induct
apoptosi
determin
whether
virusreceptor
bind
alon
suffici
apoptosi
induct
perform
complementari
experi
viru
prebound
cell
h
infect
cell
wash
cold
pb
remov
unbound
virus
incub
fresh
medium
presenc
neutral
monoclon
antibodi
specif
viral
spike
protein
fleme
et
al
ramakrishna
et
al
isotyp
control
h
cultur
move
period
time
indic
h
pi
cultur
medium
harvest
determin
viru
titer
cell
evalu
apoptosi
shown
fig
treatment
spike
neutral
antibodi
reduc
viru
titer
log
indic
neutral
antibodi
abl
block
viru
entri
even
viru
attach
significantli
treatment
inhibit
mhvinduc
apoptosi
demonstr
pi
annexin
v
analys
compar
treat
control
fig
c
taken
togeth
result
demonstr
virusreceptor
bind
necessari
suffici
induct
oligodendrocyt
apoptosi
note
cell
use
set
experi
lower
passag
therefor
exhibit
lower
background
assay
apoptosi
result
suggest
apoptot
signal
like
activ
vicin
cell
surfac
entri
discuss
introduct
two
major
apoptot
signal
fasfasl
tnfrtnf
cell
surfac
determin
whether
apoptot
pathway
trigger
mhv
infect
analyz
western
blot
abund
protein
potenti
form
preapoptot
complex
result
show
amount
fa
fadd
tradd
virtual
unchang
follow
virusinfect
h
pi
compar
mockinfect
cell
fig
b
indic
mhv
infect
activ
fa
tnfr
signal
pathway
transcript
translat
level
perform
coimmunoprecipit
cell
lysat
antibodi
specif
one
compon
detect
interact
partner
antibodi
compon
western
blot
analysi
interestingli
significantli
fadd
fa
coimmunoprecipit
antibodi
specif
liveand
uvinactiv
virusesinfect
cell
h
pi
compar
mockinfect
cell
fig
f
similarli
protein
coprecipit
antibodi
specif
fadd
virusinfect
cell
mockinfect
cell
fig
f
contrast
amount
tradd
coimmunoprecipit
antibodi
remain
similar
virusinfect
mockinfect
cell
fig
f
result
indic
mhv
infect
increas
format
fa
complex
complex
suggest
specif
activ
fa
signal
pathway
mhv
infect
addit
determin
kinet
activ
fa
signal
pathway
cell
mocktreat
treat
antimhv
receptor
antibodi
min
infect
mhv
presenc
antibodi
h
viru
titer
determin
h
pi
plaqu
assay
express
mean
sd
three
independ
experi
b
analysi
apoptosi
propidium
iodid
pi
stain
cell
either
treat
antibodi
mocktreat
describ
panel
infect
liveor
uvinactiv
mhv
h
pi
cell
stain
pi
subject
flow
cytometr
analysi
bar
graph
repres
popul
cell
indic
percentag
lowest
intens
pi
stain
data
repres
least
three
independ
experi
c
analysi
apoptosi
detect
annexin
v
bind
experi
perform
panel
b
except
detect
annexin
v
bind
cell
surfac
carri
h
pi
annexin
vegfp
assay
kit
annexin
vposit
cell
quantifi
flow
cytometri
indic
percentag
graph
statist
analysi
data
three
independ
experi
analyz
compar
mock
control
fluoresc
intens
analyz
preapoptot
complex
format
h
p
coimmunoprecipit
antifadd
antibodi
western
blot
analysi
antibodi
found
protein
significantli
increas
complex
h
pi
thereaft
h
pi
fig
establish
biolog
relev
complex
format
apoptot
signal
treat
cell
fasfc
chimera
prior
viru
infect
chimera
contain
ectodomain
fa
fc
region
immunoglobulin
place
membraneanchor
domain
fa
function
solubl
receptor
abl
block
fasligandmedi
apoptosi
ad
cell
cultur
medium
cheng
et
al
h
pi
abil
complex
format
determin
combin
coimmunoprecipit
western
blot
analysi
ex
experi
carri
essenti
describ
legend
fig
except
initi
treatment
antibodi
note
cell
mockinfect
infect
liveor
uvinactiv
mhv
h
virusbound
cell
wash
cold
pb
twice
neutral
monoclon
antibodi
specif
spike
protein
mhv
term
isotyp
control
ad
cultur
incub
anoth
hour
cultur
incub
h
allow
viru
entri
viru
titer
determin
live
virusinfect
cultur
h
pi
express
mean
sd
three
independ
experi
apoptosi
analyz
pi
stain
h
pi
b
detect
annexin
v
bind
h
pi
c
describ
legend
fig
pect
treatment
cell
fasfc
chimera
significantli
block
format
complex
level
similar
mockinfect
cell
fig
result
thu
establish
fa
signal
pathway
activ
mhv
infect
although
previous
show
activ
oligodendrocyt
mhv
infect
liu
et
al
biolog
relev
observ
apoptosi
directli
establish
extend
studi
treat
cell
inhibitor
examin
apoptosi
found
significantli
activ
liveand
uvinactiv
virus
h
pi
increas
mockinfect
cell
treatment
cell
inhibitor
almost
complet
block
activ
p
fig
perform
piand
annexin
v
stain
infect
oligodendrocyt
shown
fig
cell
phase
mockinfect
cell
reveal
pi
stain
follow
flow
cytometr
analysi
wherea
cell
phase
cell
infect
liveand
uv
h
pi
cell
lyse
equival
amount
protein
sampl
analyz
western
blot
use
antibodi
specif
individu
protein
indic
right
panel
use
intern
control
b
quantif
protein
band
shown
panel
intens
band
determin
densitometri
express
rel
amount
control
lane
set
c
detect
complex
format
coimmunoprecipit
western
blot
cell
infect
lyse
describ
panel
cell
lysat
use
precipit
antibodi
specif
immunocomplex
resolv
sdspage
analyz
western
blot
antibodi
specif
individu
protein
indic
right
panel
note
lysat
sampl
use
immunoprecipit
approxim
time
use
western
blot
analysi
shown
panel
experi
perform
panel
c
except
antifadd
antibodi
use
immunoprecipit
antibodi
western
blot
e
experi
perform
panel
c
use
antibodi
immunoprecipit
except
antitradd
antibodi
use
western
blot
analysi
f
quantif
protein
band
shown
panel
c
e
describ
panel
b
g
kinet
complex
format
virusinfect
mockinfect
cell
complex
precipit
antibodi
specif
fadd
detect
presenc
antibodi
specif
western
blot
analysi
use
control
protein
load
inactiv
virus
respect
cell
treat
inhibitor
percentag
cell
decreas
respect
cell
infect
liveand
uvinactiv
virus
still
significantli
higher
mockinfect
cell
differ
group
statist
signific
p
similar
result
obtain
cell
stain
annexin
vat
h
pi
fig
result
indic
mhvinduc
apoptosi
oligodendrocyt
mediat
least
part
activ
data
also
indic
activ
like
mediat
viru
entri
requir
viral
replic
sinc
liveand
uvinactiv
virus
capabl
activ
induc
apoptosi
similar
extent
determin
whether
activ
mediat
upstream
fa
signal
pathway
cell
pretreat
fasfc
chimer
protein
h
pretreat
cell
infect
mhv
moi
presenc
fasfc
chimera
follow
infect
h
inoculum
remov
replac
fresh
medium
activ
apoptosi
evalu
shown
fig
treatment
cell
fasfc
chimera
almost
complet
block
activ
activ
induc
infect
liveand
uvinactiv
virus
p
similarli
number
cell
decreas
significantli
virusinfect
cell
livevirusinfect
cell
uvinactiv
virusinfect
cell
follow
chimera
treatment
p
fig
also
slight
decreas
cell
number
phase
mockinfect
cell
fig
may
suggest
spontan
apoptosi
oligodendrocyt
also
inhibit
fasfc
treatment
consist
pi
stain
apoptosi
analyz
annexin
v
stain
h
pi
apoptot
cell
reduc
respect
livevirusand
uvinactiv
virusinfect
cell
fasfc
chimera
treatment
p
fig
thu
conclud
activ
activ
induct
apoptosi
mediat
via
activ
fa
signal
pathway
mhv
infect
although
experi
exclud
involv
signal
pathway
see
recent
show
mitochondri
pathway
activ
mhvinfect
liu
et
al
determin
whether
mhvinduc
mitochondri
signal
depend
activ
fa
signal
pathway
treat
cell
fasfc
chimera
determin
reloc
cytochrom
c
activ
found
without
treatment
fasfc
chimera
ratio
cytoplasm
mitochondri
fraction
cytochrom
c
liveand
uvinactiv
virus
respect
cell
treat
fasfc
chimera
ratio
revers
two
virus
respect
similar
mockinfect
cell
ratio
fig
likewis
treatment
cell
fasfc
chimera
drastic
block
activ
reduct
activ
virus
fig
result
indic
activ
mitochondri
apoptot
pathway
mhv
infect
larg
depend
activ
fa
signal
pathway
oligodendrocyt
mechan
mhv
induc
oligodendrocyt
apoptosi
current
unknown
begun
address
issu
current
studi
determin
event
viru
life
cycl
trigger
fa
signal
pathway
infect
uvinactiv
viru
activ
apoptosi
liu
et
al
work
like
event
viru
entri
trigger
apoptosi
therefor
specif
sought
determin
whether
initi
step
viru
entri
ie
virusreceptor
bind
second
step
ie
viruscel
fusion
trigger
observ
apoptosi
employ
two
complementari
approach
first
use
neutral
antibodi
viral
receptor
treatment
cell
receptor
antibodi
demonstr
virusreceptor
bind
necessari
trigger
apoptosi
receptorantibodi
bind
induc
apoptosi
sinc
uninfect
h
pi
activ
cell
lysat
detect
caspas
colorimetr
proteas
assay
kit
use
specif
substrat
describ
materi
method
activ
virusinfect
cell
express
mean
sd
three
independ
experi
fold
increas
mockinfect
control
set
b
analysi
apoptosi
pi
stain
cell
infect
treat
describ
panel
h
pi
cell
stain
pi
subject
flow
cytometr
analysi
bar
graph
repres
popul
cell
indic
percentag
lowest
intens
pi
stain
data
repres
least
three
independ
experi
c
analysi
apoptosi
detect
annexin
v
bind
experi
perform
panel
b
except
detect
annexin
v
bind
cell
surfac
carri
h
pi
annexin
vegfp
assay
kit
annexin
vposit
cell
quantifi
flow
cytometri
indic
percentag
graph
statist
analysi
data
three
independ
experi
analyz
compar
control
mocktreat
mockinfect
fluoresc
intens
cell
exhibit
apoptosi
even
though
cell
treat
receptor
antibodi
ligand
fig
interpret
support
second
experi
apoptosi
also
block
neutral
antispik
protein
antibodi
even
though
viru
prebound
receptor
fig
suggest
receptor
bind
alon
suffici
apoptosi
induct
therefor
second
step
ie
fusion
like
involv
trigger
apoptosi
consist
interpret
previou
find
endosom
ph
elev
ammonium
chlorid
chloroquin
bafilomycin
block
virusreceptor
bind
block
virusendosom
membran
fusion
phdepend
mutant
mhv
gallagh
et
al
apoptosi
inhibit
liu
et
al
addit
neutral
antibodi
shown
also
inhibit
viruscel
fusion
fleme
et
al
ramakrishna
et
al
taken
togeth
find
suggest
viru
fusion
entri
like
initi
apoptot
signal
ie
fa
activ
howev
mechanist
detail
activ
remain
investig
studi
demonstr
infect
differenti
oligodendrocyt
cell
line
mhv
result
activ
activ
apoptosi
wherea
treatment
cell
inhibitor
suppress
activ
apoptosi
fig
indic
signal
pathway
involv
mhvinduc
oligodendrocyt
apoptosi
furthermor
identifi
fa
upstream
apoptot
signal
activ
mhv
infect
conclus
support
three
piec
evid
first
activ
apoptosi
follow
mhv
infect
block
treatment
cell
inhibitori
solubl
receptor
fasfc
chimera
prior
viru
infect
fig
second
signific
increas
death
receptor
complex
consist
fa
fadd
follow
mhv
infect
complet
block
treatment
cell
fasfc
solubl
receptor
fig
death
receptor
complex
began
increas
h
pi
fig
time
point
apoptosi
began
detect
albeit
low
level
liu
et
al
third
releas
cytochrom
c
mitochondria
cytoplasm
activ
caus
mhv
infect
prevent
treatment
cell
fasfc
solubl
receptor
fig
find
thu
establish
fa
activ
primari
apoptot
signal
trigger
mhv
infect
interestingli
although
usual
activ
fa
tnfr
tnfr
signal
pathway
appear
activ
mhv
infect
instanc
increas
amount
tradd
detect
death
receptor
complex
coimmunoprecipit
western
blot
analysi
fig
thu
appear
mhv
infect
specif
activ
fa
signal
pathway
oligodendrocyt
note
rel
high
background
preapoptot
complex
mockinfect
cell
shown
fig
like
due
two
chief
reason
first
total
protein
amount
sampl
coimmunoprecipit
experi
time
higher
use
western
blot
alon
see
fig
like
much
lower
amount
protein
use
immunoprecipit
background
protein
complex
mockinfect
cell
would
detect
level
second
termin
differenti
oligodendrocyt
usual
undergo
apoptosi
low
level
may
contribut
background
complex
format
nevertheless
increas
amount
complex
follow
viru
infect
signific
experiment
condit
previous
report
activ
mitochondri
apoptot
pathway
trigger
part
activ
cleavag
bid
also
part
independ
pathway
liu
et
al
latter
conclus
base
find
cytochrom
c
releas
activ
partial
inhibit
treatment
inhibitor
liu
et
al
show
treatment
inhibitor
also
partial
block
apoptosi
induc
viru
infect
annexin
vposit
still
much
higher
mockinfect
untreat
cell
annexin
vposit
fig
howev
higher
concentr
inhibitor
complet
inhibit
activ
significantli
increas
effect
inhibit
apoptosi
data
shown
thu
possibl
mhvinduc
apoptosi
via
independ
pathway
may
explain
part
result
show
treatment
cell
fasfc
solubl
receptor
exert
greater
inhibitori
effect
apoptosi
reduct
inhibitor
reduct
apoptosi
measur
annexin
v
stain
earlier
time
h
pi
compar
fig
fig
may
suggest
activ
fa
signal
pathway
activ
pathway
also
downstream
pathway
although
yet
examin
pathway
one
candid
pathway
potenti
trigger
upon
fa
activ
daxx
like
fadd
daxx
bind
death
domain
fa
activ
faddindepend
death
pathway
involv
stressactiv
cjun
kinas
jnk
yang
et
al
phosphoryl
jnk
either
activ
inhibit
lead
apoptosi
via
mitochondri
pathway
uvinactiv
viru
uvv
mockinfect
mock
either
untreat
treat
fasfc
chimera
h
pi
cell
harvest
cytosol
cytosol
mitochondri
mito
fraction
separ
differenti
centrifug
use
cytochrom
c
releas
assay
kit
describ
materi
method
protein
separ
sdspage
gel
transfer
nitrocellulos
membran
detect
western
blot
analysi
cytochrom
c
detect
western
blot
cytochrom
cspecif
antibodi
includ
kit
amount
protein
band
quantifi
densitometr
analysi
upv
softwar
effici
releas
cytochrom
c
mitochondri
fraction
cytosol
fraction
express
ratio
cytochrom
c
cytosol
fraction
mitochondri
fraction
c
shown
bottom
panel
b
inhibit
activ
fasfc
chimera
cell
infect
mhv
treat
fasfc
chimera
describ
panel
h
pi
activ
cell
lysat
detect
caspas
colorimetr
proteas
assay
kit
use
specif
substrat
describ
materi
method
activ
virusinfect
cell
express
mean
sd
three
independ
experi
fold
increas
mockinfect
control
set
may
explain
inhibitor
complet
block
transloc
bax
mitochondri
apoptot
pathway
induc
mhvinfect
liu
et
al
possibl
warrant
investig
base
current
previou
find
liu
et
al
liu
et
al
liu
zhang
propos
follow
model
activ
oligodendrocyt
apoptosi
mhv
infect
fig
initi
viru
infect
spike
protein
interact
mhv
receptor
induc
cleavag
conform
chang
spike
protein
lead
fusion
viral
envelop
cytoplasma
membran
fusion
andor
postfus
event
trigger
activ
fa
apoptot
signal
pathway
yet
undefin
mechan
activ
fa
signal
pathway
facilit
recruit
fadd
death
receptor
complex
lead
activ
activ
activ
effector
caspas
lead
apoptosi
cleavag
bid
cleav
bid
transloc
mitochondria
lead
activ
mitochondri
apoptot
pathway
turn
lead
releas
cytochrom
c
activ
activ
activ
effector
caspas
lead
apoptosi
mitochondria
via
posit
feedback
mechan
mhv
infect
oligodendrocyt
may
also
activ
altern
minor
daxx
jnk
bax
mitochondria
pathway
follow
activ
fa
although
much
pathway
remain
establish
experiment
worth
note
howev
find
vitrodifferenti
cell
line
might
faith
reflect
vivo
situat
requir
test
anim
cell
perman
undifferenti
type
oligodendrocyteastrocyt
progenitor
cell
origin
establish
primari
neural
cell
cultur
deriv
brain
newborn
spraguedawley
rat
pup
day
postnat
mcnulti
et
al
condit
cultur
medium
cell
maintain
undifferenti
progenitor
phenotyp
indefinit
liu
et
al
defin
cultur
condit
cell
differenti
matur
oligodendrocyt
evidenc
appear
myelin
basic
protein
liu
et
al
matur
oligodendrocyt
suscept
mhv
infect
howev
viru
replic
sever
restrict
matur
oligodendrocyt
cell
exhibit
strong
express
viral
antigen
h
pi
liu
et
al
matur
oligodendrocyt
thu
use
viru
infect
throughout
studi
mous
astrocytoma
dbt
cell
hirano
et
al
cultur
eagl
minimum
essenti
medium
emem
use
viru
propag
viru
plaqu
assay
liu
et
al
mous
hepat
viru
mhv
strain
jhm
obtain
dr
michael
lai
laboratori
univers
southern
california
school
medicin
viru
prepar
purifi
sucros
cushion
viru
titer
determin
plaqu
assay
dbt
cell
describ
previous
liu
et
al
multipl
infect
moi
use
throughout
studi
inhibitor
purchas
calbiochem
dissolv
dimethyl
sulfoxid
dmso
cytotox
determin
oligodendrocyt
noncytotox
concentr
use
subsequ
experi
recombin
rat
fasfc
chimera
cat
r
system
inc
prepar
phosphatebuff
salin
pb
use
final
concentr
monoclon
antibodi
specif
mhv
receptor
kindli
provid
dr
kay
holm
univers
colorado
denver
dveksler
et
al
monoclon
antibodi
mhv
spike
protein
gift
dr
john
fleme
univers
wisconsin
madison
properti
character
describ
fleme
et
al
ramakrishna
et
al
mous
purchas
sigma
use
isotyp
control
antispik
antibodi
caspas
assay
carri
essenti
describ
previous
liu
et
al
briefli
cell
grown
dish
either
mockinfect
emem
infect
mhv
moi
cell
collect
variou
time
point
postinfect
pi
scrape
split
plate
spun
min
follow
remov
supernat
lysi
cell
determin
caspas
activ
carri
fluorometr
caspas
assay
kit
activ
assay
kit
activ
assay
kit
accord
manufactur
instruct
oncogen
research
product
fluoresc
read
fluoresc
plate
reader
spectra
max
molecular
devic
capabl
measur
excit
nm
emiss
nm
inactiv
viru
uv
light
purifi
viru
dilut
concentr
plaqu
form
unit
pfu
per
ml
serumfre
medium
aliquot
ml
ad
well
tissu
cultur
plate
plate
place
ice
distanc
cm
uv
light
uv
crosslink
fisher
scientif
expos
uv
light
energi
min
viral
inactiv
confirm
titrat
sampl
uv
exposur
absenc
cytopath
effect
cpe
inocul
dbt
cell
monolay
uvirradi
viru
sampl
preliminari
experi
indic
exposur
uv
light
complet
inactiv
mhv
infect
apoptot
nuclei
contain
subdiploid
dna
content
determin
propidium
iodid
stain
flow
cytometr
analysi
describ
previous
liu
et
al
briefli
variou
time
point
pi
adher
float
cell
collect
centrifug
min
pellet
cell
resuspend
phosphatebuff
salin
pb
centrifug
fix
icecold
ethanol
incub
overnight
cell
centrifug
resuspend
pb
incub
propidium
iodid
ml
rnase
sigma
aliquot
cell
subject
flow
cytometr
analysi
fac
calibur
flow
cytomet
equip
argonion
laser
nm
data
acquir
analyz
cellquest
softwar
becton
dickinson
assay
apoptosi
annexin
v
annexin
v
bind
assay
carri
describ
liu
et
al
briefli
cell
infect
mhv
moi
mockinfect
control
h
pi
approxim
cell
collect
centrifug
determin
apoptosi
cell
resuspend
annexin
v
bind
buffer
incub
annexin
venhanc
green
fluoresc
protein
egfp
room
temperatur
min
dark
use
assay
kit
accord
manufactur
instruct
bio
vision
inc
mountain
view
ca
cell
analyz
flow
cytometri
use
channel
detect
annexin
vegfp
cytochrom
c
releas
apoptosi
assay
kit
calbiochem
cat
use
detect
cytochrom
c
accord
manufactur
instruct
describ
liu
et
al
briefli
cell
collect
resuspend
cytosol
extract
buffer
homogen
icecold
tissu
grinder
cell
lysat
separ
mitochondri
cytosol
fraction
differenti
centrifug
protein
analyz
western
blot
monoclon
antibodi
specif
cytochrom
c
follow
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
gel
detect
protein
complex
cell
either
mockinfect
infect
mhv
mocktreat
treat
fasfc
chimera
protein
indic
time
point
pi
cell
lyse
lysi
buffer
mm
trishcl
ph
mm
nacl
sodium
deoxychol
nonidet
contain
proteas
inhibitor
cocktail
tablet
roch
mannheim
germani
cell
lysat
clarifi
cell
debri
centrifug
protein
concentr
measur
use
biorad
protein
assay
kit
biorad
cellular
protein
equival
number
cell
sampl
precipit
antibodi
specif
detect
fa
fadd
tradd
fadd
detect
h
rock
platform
immunocomplex
precipit
protein
aagaros
bead
denatur
separ
sdspage
analyz
western
blot
describ
previous
liu
et
al
primari
antibodi
use
studi
includ
rabbit
polyclon
antibodi
specif
fa
cat
ngml
goat
polyclon
antibodi
specif
fadd
cat
ngml
rabbit
polyclon
antibodi
tradd
cat
ngml
mous
monoclon
antibodi
specif
cat
ngml
antibodi
purchas
santa
cruz
biotechnolog
inc
monoclon
antibodi
specif
intern
control
purchas
sigma
presenc
specif
protein
visual
enhanc
chemiluminesc
ecl
system
use
peracid
substrat
amersham
pharmacia
biotech
follow
autoradiographi
exposur
time
rang
min
result
express
mean
standard
deviat
sd
mean
valu
compar
use
student
ttest
valu
p
p
p
consid
statist
signific
